The blockade of AMPA-kainate and NMDA receptors in the dorsal periaqueductal gray reduces the effects of diazepam withdrawal in rats

Pharmacology Biochemistry and Behavior

Volumn 87, Issue 2, 2007, Pages 250-257

  Souza Pinto, Luiz F S ^a   Castilho, Vanessa M ^a   Brandão, Marcus Lira ^a   Nobre, Manoel Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Diazepam withdrawal; Fear; Glutamate; Periaqueductal gray

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; AMPA RECEPTOR; DIAZEPAM; EXCITATORY AMINO ACID; GLUTAMIC ACID DIETHYL ESTER; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; FEAR; FOOTSHOCK; NEUROTRANSMISSION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; WITHDRAWAL SYNDROME;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; CONDITIONING, OPERANT; DIAZEPAM; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; HYPNOTICS AND SEDATIVES; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION;

ANIMALIA; RATTUS;

EID: 34250710675     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.04.021     Document Type: Article

References (47)

1. Allison C., and Pratt J.A. Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics. Neuropsychopharmacology 31 (2006) 602-619
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (2000), American Psychiatric Association, Washington, DC
3. Andrews N., File S.E., Fernandes C., Gonzalez L.E., and Barnes N.M. Evidence that the median raphe nucleus-dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) 130 (1997) 228-234
4. Baldwin H.A., and File S.E. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull 20 (1988) 603-606
5. Baldwin H.A., and File S.E. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety. Psychopharmacology (Berl) 97 (1989) 424-426
6. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46 (1995) 575-605
7. Benvenga M.J., and Spaulding T.C. Amnesic effect of the novel anticonvulsant MK-801. Pharmacol Biochem Behav 30 (1988) 205-207
8. Biggio G., Concas A., Corda M.G., Giorgi O., Sanna E., and Serra M. GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther 48 (1990) 121-142
9. Brandão M.L., Anseloni V.Z., Pandossio J.E., De Araujo J.E., and Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci Biobehav Rev 23 (1999) 863-875
10. Brandão M.L., Troncoso A.C., de Souza Silva M.A., and Huston J.P. The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations. Eur J Pharmacol 463 (2003) 225-233
11. Brandão M.L., Borelli K.G., Nobre M.J., Santos J.M., Albrechet-Souza L., Oliveira A.R., et al. Gabaergic regulation of the neural organization of fear in the midbrain tectum. Neurosci Biobehav Rev 29 (2005) 1299-1311
12. Carboni E., Imperato A., Perezzani L., and Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28 (1989) 653-661
13. Danysz W., Wroblewsky J.T., and Costa E. Learning impairment in rats by N-methyl-D-aspartate receptor antagonists. Neuropharmacology 27 (1988) 653-656
14. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988) 5274-5278
15. Deroche-Gamonet V., Belin D., and Piazza P.V. Evidence for addiction-like behavior in the rat. Science 305 (2004) 1014-1017
16. Emmett-Oglesby M., Spencer D., Lewis M., Elmesallamy F., and Lal H. Anxiogenic aspects of diazepam withdrawal can be detected in animals. Eur J Pharmacol 92 (1983) 127-130
17. Fanselow M.S. The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. In: DePaulis A., and Bandler R. (Eds). The midbrain periaqueductal gray matter: functional, anatomical and immunohistochemical organization (1991), Plenum, New York
18. Fanselow M.S. Neural organization of the defensive behavior system responsible for fear. Psychon Bull Rev (1994) 429-438
19. File S.E. The history of benzodiazepine dependence: a review of animal studies. Neurosci Biobehav Rev 14 (1990) 135-146
20. File S.E., and Andrews N. Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal. Psychopharmacology (Berl) 105 (1991) 578-582
21. File S.E., Baldwin H.A., and Aranko K. Anxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance. Brain Res Bull 19 (1987) 607-610
22. File S.E., Mabbutt P.S., and Andrews N. Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen. Psychopharmacology (Berl) 104 (1991) 62-66
23. Finlay J.M., Damsma G., and Fibiger H.C. Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology (Berl) 106 (1992) 202-208
24. Gibson E.L., Barnfield A.M., and Curzon G. Dissociation of effects of chronic diazepam treatment and withdrawal on hippocampal dialysate 5-HT and mCPP-induced anxiety in rats. Behav Pharmacol 7 (1996) 185-193
25. Hlinak Z., and Krejci I. MK-801 induced amnesia for the elevated plus-maze in mice. Behav Brain Res 131 (2002) 221-225
26. Impagnatiello F., Pesold C., Longone P., Caruncho H., Fritschy J.M., Costa E., et al. Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49 (1996) 822-831
27. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
28. Lingford-Hughes A., and Nutt D. Neurobiology of addiction and implications for treatment. Br J Psychiatry 182 (2003) 97-100
29. Markou A., Kosten T.R., and Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18 (1998) 135-174
30. Marks J. The benzodiazepines: use, oversuse, misuse, abuse (1978), MTP Press, Lancaster, England
31. Martijena I.D., Tapia M., and Molina V.A. Altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats. Brain Res 712 (1996) 239-244
32. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
33. Nobre M.J., Ribeiro dos S.N., Aguiar M.S., and Brandao M.L. Blockade of mu- and activation of kappa-opioid receptors in the dorsal periaqueductal gray matter produce defensive behavior in rats tested in the elevated plus-maze. Eur J Pharmacol 404 (2000) 145-151
34. Nobre M.J., Borelli K.G., and Brandão M.L. Fast-acting excitatory amino acids are involved in the enhancement of the aversiveness of the electrical stimulation of the inferior colliculus by systemic injections of muscimol. Life Sci 71 (2002) 2961-2972
35. Nobre M.J., Sandner G., and Brandao M.L. Enhancement of acoustic evoked potentials and impairment of startle reflex induced by reduction of GABAergic control of the neural substrates of aversion in the inferior colliculus. Hear Res 184 (2003) 82-90
36. Nobre M.J., Lopes M.G., and Brandão M.L. Defense reaction mediated by NMDA mechanisms in the inferior colliculus is modulated by GABAergic nigro-collicular pathways. Brain Res 999 (2004) 124-131
37. Pandóssio J.E., and Brandão M.L. Defensive reactions are counteracted by midazolam and muscimol and elicited by activation of glutamate receptors in the inferior colliculus of rats. Psychopharmacology (Berl) 142 (1999) 360-368
38. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1997), Academic Press, New York
39. Pokk P., and Zharkovsky A. Small platform stress attenuates the anxiogenic effect of diazepam withdrawal in the plus-maze test. Behav Brain Res 97 (1998) 153-157
40. Pratt J.A., Brett R.R., and Laurie D.J. Benzodiazepine dependence: from neural circuits to gene expression. Pharmacol Biochem Behav 59 (1998) 925-934
41. Santos P., Bittencourt A.S., Schenberg L.C., and Carobrez A.P. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats. Neuropharmacology 51 (2006) 203-212
42. Schleimer S.B., Johnston G.A., and Henderson J.M. Novel oral drug administration in an animal model of neuroleptic therapy. J Neurosci Methods 146 (2005) 159-164
43. Stephens D.N. A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands. Behav Pharmacol 6 (1995) 425-446
44. Steppuhn K.G., and Turski L. Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci U S A 90 (1993) 6889-6893
45. Tang A.H., and Ho P.M. Both competitive and non-competitive antagonists of N-methyl-d-aspartic acid disrupt brightness discrimination in rats. Eur J Pharmacol 151 (1988) 143-146
46. Tsuda M., Shimizu N., and Suzuki T. Contribution of glutamate receptors to benzodiazepine withdrawal signs. Jpn J Pharmacol 81 (1999) 1-6
47. VonVoigtlander P.F., and Lewis R.A. A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists. Pharmacol Methods 26 (1991) 1-5